Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oliceridine for Postoperative Analgesia After CABG
ChiCTR2500101324Phase 4Not yet recruiting
- Sponsor
- Fuwai Hospital, Chinese Academy of Medical Sciences, Shenzhen Hospital
- Start
- May 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of oliceridine in postoperative pain (2 arms), sponsored by Fuwai Hospital, Chinese Academy of Medical Sciences, Shenzhen Hospital. Primary endpoint: Opioid-induced respiratory depression (OIRD). Planned start May 2025; status: not yet recruiting.
02
Drugs
oliceridine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on ChiCTR2500101324.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500101324.